Sajo Kaduthanam - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sajo Kaduthanam

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of Personalized Medicine|September 8, 2019

Precision Oncology-The Quest for EvidenceTheodoros G Soldatos, Sajo Kaduthanam, David B Jackson

Lung Cancer (Amsterdam, Netherlands)|February 16, 2013

Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patientsSajo Kaduthanam, Stephan Gade, Michael Meister, et al.

International Journal of Molecular Sciences|June 4, 2020

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH GuideYosuke Hirotsu, Udo Schmidt-Edelkraut, Hiroshi Nakagomi, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of Personalized Medicine|September 8, 2019

Precision Oncology-The Quest for EvidenceTheodoros G Soldatos, Sajo Kaduthanam, David B Jackson

Lung Cancer (Amsterdam, Netherlands)|February 16, 2013

Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patientsSajo Kaduthanam, Stephan Gade, Michael Meister, et al.

International Journal of Molecular Sciences|June 4, 2020

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH GuideYosuke Hirotsu, Udo Schmidt-Edelkraut, Hiroshi Nakagomi, et al.

Pageof 1